| Location | South San Francisco, CA |
| Industry | Biotechnology/Pharmaceuticals |
| Company Size | 2,500 to 4,999 employees |
| Website | https://www.astellas.com/us/ |
Scientist II, BioConjugation
About Astellas
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Learn more at Astellas.com.
Are you driven to make a real difference in the lives of patients?
We're seeking passionate individuals who thrive in dynamic environments, embrace new ideas, and aren't afraid to take intelligent risks. People who act with unwavering integrity and are deeply committed to making a tangible impact.
Purpose & Scope
Astellas Oncology Research is seeking a highly motivated scientist to join our Antibody-Drug Conjugates (ADC) Group. In this role, you will contribute to the design, conjugation, purification, and characterization of next-generation bioconjugate therapeutics, including antibody-drug conjugates (ADCs), degrader-antibody conjugates (DACs), dual-payload ADCs, and other emerging modalities. Leveraging your expertise in antibody conjugation and bioconjugate development, you will play a key role in advancing Astellas' innovative oncology pipeline and helping deliver transformative therapies to patients.
Role and Responsibilities